Tweet
Neuromuscul Disord
. 2020 Aug 12;S0960-8966(20)30551-4.
doi: 10.1016/j.nmd.2020.08.354. Online ahead of print.
Guillain-Barr?-Strohl syndrome and COVID-19: Case report and literature review
Laura Diez-Porras 1 , Enric Verg?s 2 , Francisco Gil 2 , M Jos? Vidal 2 , Joan Massons 2 , Adri? Arboix 2
Affiliations
- PMID: 32912716
- DOI: 10.1016/j.nmd.2020.08.354
Abstract
In recent months, the new beta-coronavirus has caused a pandemic with symptoms affecting mainly the respiratory system. It is established that the virus may play a neurotropic role and in recent months several cases of Guillain-Barr?-Strohl syndrome (GBS) have been reported in patients infected with COVID-19. We report the case of a 54-year old patient with acute demyelinating polyneuropathy during infection by SARS-CoV-2 who progressed clinically to require assisted ventilation. After several weeks of specific symptomatic treatment, the patient had a favorable outcome. In conclusion, despite being a rare complication, we think it is important to consider the possibility of diffuse involvement of the peripheral nervous system in patients with COVID-19 to adjust clinical monitoring and treatment in these cases.
Keywords: Covid-19; Guillain-Barr?; SARS-CoV-2.